News Express: UM MITMI holds committee meeting

新聞快訊:澳大澳門轉化醫學創新研究院召開會議

 

鍾南山(中)
Zhong Nanshan (middle)

 


澳大澳門轉化醫學創新研究院召開會議

澳門大學澳門轉化醫學創新研究院指導委員會暨學術委員會一屆二次會議以線上線下結合的形式在廣州及澳門召開,與會專家綜合分析了研究院的概況,高度肯定其發展方向,對該院的監管科學研究表示讚許。

會議設兩個專題,分別由研究院指導委員會委員楊子峰和學術委員會副主任唐健元主持。研究院代副院長趙永華匯報了研究院2022年在國家技術轉移示範機構、項目轉化、監管科學、研究交流等方面的工作進展,以及2023年的工作規劃。與會專家充分肯定了研究院在過去一年的進展和成果,同時對研究院下一步工作提出一系列指導性建議。

研究院指導委員會主席暨學術委員會主任鍾南山對研究院2022年工作予以高度認可,並就後續工作提出兩點建議。第一,傾盡各方力量,爭取國家技術轉移示範機構落地;國家技術轉移示範機構落地,澳門具有很大的地域優勢,希望各部門牢牢抓住國家對澳門的戰略部署和資源傾斜。第二,以點帶面,優選一至兩個具體中藥品種入手,聯合國家藥品監督管理局、廣東省藥品監督管理局、澳門藥監局及香港衛生署共同解決目前中藥審評審批政策問題;此外,粵港澳學術界、產業界和監管機構聯合發展,制定大灣區中藥統一標準,力爭未來實現“一研三報”,互認互通。

隨後,與會學術委員共同審議並通過《澳門大學澳門轉化醫學創新研究院開放課題管理辦法》及《2023年度澳門大學澳門轉化醫學創新研究院開放課題申報指南》兩個文件。

出席會議的還包括澳門經濟及科技發展局代副局長謝永強,澳大副校長葛偉代表、澳大中華醫藥研究院院長陳新,澳門科學技術發展基金行政委員會委員葉桂林,澳門經濟及科技發展局科技廳代廳長陳祖榮,指導委員會委員鍾惟月、學術委員會副主任李紹平,澳大中華醫藥研究院創始院長王一濤,澳門科技大學副校長姜志宏,中國醫學科學院藥用植物研究所所長孫曉波,廣州中醫藥大學第一附屬醫院副院長楊忠奇,上海中醫藥大學協同創新中心常務副主任張磊,江蘇鼎泰藥研首席科學官竇金輝,廣東省科學院測試分析研究所(中國廣州分析測試中心)所長(主任)陳江韓。

欲瀏覽官網版可登入以下連結:
https://www.um.edu.mo/zh-hant/news-and-press-releases/presss-release/detail/55791/


UM MITMI holds committee meeting

The Steering Committee and the Academic Committee of the Macau Institute for Translational Medicine and Innovation (MITMI) of the University of Macau (UM) recently held their second meeting in Guangzhou and Macao, which combined both online and in-person elements. Experts participating in the meeting comprehensively evaluated MITMI’s recent development, spoke highly of its development direction, and recognised its achievements in regulatory science research.

The meeting featured two panel discussions, chaired by Yang Zifeng, member of the MITMI Steering Committee, and Tang Jianyuan, deputy director of the MITMI Academic Committee, respectively. Zhao Yonghua, interim associate head of MITMI, presented the work progress of the institute in 2022 in the application of a national technology transfer demonstration institution in Macao, project translation, regulatory science, research and exchanges, as well as the work plan for 2023. The participating experts fully recognised MITMI’s development and achievements over the past year and provided a series of suggestions for the institute’s future work.

Zhong Nanshan, president of the MITMI Steering Committee and director of the MITMI Academic Committee, spoke highly of the institute’s achievements in 2022 and made two suggestions. Firstly, MITMI should make every effort for the application of a national technology transfer demonstration institution in Macao. Macao has a great geographical advantage, which is conducive to the establishment of a national technology transfer demonstration institution. It is hoped that all parties will leverage the strategic planning and resources provided by the country for Macao. Secondly, MITMI should promote work in all areas by drawing upon the experience gained on key points. By selecting one or two traditional Chinese medicine (TCM), the institute can work with the National Medical Products Administration, the Guangdong Medical Products Administration, the Pharmaceutical Administration Bureau of Macao, and the Department of Health of Hong Kong to address issues related to the current TCM evaluation and approval regulation. In addition, the academia, industry, and regulatory bodies in Guangdong, Hong Kong and Macao should consider working together to formulate common standards for TCM in the Greater Bay Area in order to achieve mutual recognition and communication.

The MITMI Academic Committee members then reviewed and approved the Regulations for Open Research Projects Management of the Macau Institute for Translational Medicine and Innovation of the University of Macau, as well as the Application Guidelines for Open Research Projects of the Macau Institute for Translational Medicine and Innovation of the University of Macau in 2023.

Guest attending the meeting included Che Weng Keong, acting deputy director of the Economic and Technological Development Bureau of Macao; Chen Xin, director of the Institute of Chinese Medical Sciences of UM, representative of UM Vice Rector Ge Wei; Ip Kuai Lam, member of the Administrative Committee of the Science and Technology Development Fund of Macao; Chan Chou Weng. acting head of the Technology Department of the Economic and Technological Development Bureau of Macao; Zhong Weiyue, member of the MITMI Steering Committee; Li Shaoping, deputy director of the MITMI Academic Committee; Wang Yitao, founding director of the Institute of Chinese Medical Sciences of UM; Jiang Zhihong, vice president of the Macau University of Science and Technology; Sun Xiaobo, director of the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences; Yang Zhongqi, deputy director of the First Affiliated Hospital of the Guangzhou University of Chinese Medicine; Zhang Lei, executive deputy director of Shanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine; Dou Jinhui, chief scientific officer of Jiangsu Tripod Preclinical Research Laboratories Co, Ltd; and Chen Jianghan, director of the Institute of Analysis, Guangdong Academy of Sciences (China National Analytical Center, Guangzhou).

To read the news on UM’s official website, please visit the following link:
https://www.um.edu.mo/news-and-press-releases/press-release/detail/55791/